<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1622">
  <stage>Registered</stage>
  <submitdate>11/07/2007</submitdate>
  <approvaldate>11/07/2007</approvaldate>
  <nctid>NCT00500032</nctid>
  <trial_identification>
    <studytitle>Blood Collection for Use in Serological Assay Development From Healthy Adult Volunteers</studytitle>
    <scientifictitle>Blood Collection for Use in Serological Assay Development From Healthy Adult Volunteers Who Completed Study 6108A1-500</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>6108A1-1000</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Healthy</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - blood draw

Experimental: Arm 1 - Active Comparator for all subjects enrolled in 6108A1-500


Treatment: surgery: blood draw
Blood draw from subjects previously vaccinated in 6108A1-500 trial

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Primary objective is to obtain blood volumes (approximately 200 to 470 mL per bleed) from volunteer donors who previously completed study 6108A1-500, for use in serological assay development.</outcome>
      <timepoint>1 Year</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Main 

          1. Completed study 6108A1-500.

          2. Hemoglobin level =12.0 and =16.5 g/dL for female subjects and =13.0 and =18.5 g/dL for
             male subjects.

          3. Body weight =45 and =120 kg.

          4. Systolic blood pressure &gt;90 and &lt;180 mm Hg.

          5. Diastolic blood pressure &gt;60 and &lt;100 mm Hg.

          6. Able to be contacted by telephone.

          7. For all female subjects: have a negative urine pregnancy test unless the subject is
             surgically sterile.

        Main</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>25</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>1. Bleeding diathesis or condition associated with prolonged bleeding time.

          2. Prior antibiotic use (within 14 days).

          3. Any clinically significant chronic disease that, in the investigator's judgment may be
             worsened by blood draw.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3 />
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>87</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/08/2008</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD,SA,WA</recruitmentstate>
    <hospital> - Herson</hospital>
    <hospital> - North Adealaide</hospital>
    <hospital> - Perth</hospital>
    <postcode>4006 - Herson</postcode>
    <postcode>5006 - North Adealaide</postcode>
    <postcode>6840 - Perth</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Wyeth is now a wholly owned subsidiary of Pfizer</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Subjects who have completed study 6108A1-500, in which our experimental meningoccal B vaccine
      or placebo was administered, will be approached for inclusion into this study which is purely
      for blood draw. The sera will be used for assay development.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00500032</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Medical Monitor</name>
      <address>Wyeth is now a wholly owned subsidiary of Pfizer</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>